ResearcherFudan UniversityNo recent work listed

Yuanyuan Pei

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper

Papers 1

Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. Co-author DOI 10.1002/smll.201900631 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qian Zhang · 1 shared paper, 2019 · strength 0.08
- Paper Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. DOI 10.1002/smll.201900631 ↗
Chen Liang · 1 shared paper, 2019 · strength 0.08
- Paper Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. DOI 10.1002/smll.201900631 ↗
Yukun Huang · 1 shared paper, 2019 · strength 0.08
- Paper Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. DOI 10.1002/smll.201900631 ↗
Jingxian Feng · 1 shared paper, 2019 · strength 0.08
- Paper Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. DOI 10.1002/smll.201900631 ↗
Jun Chen · 1 shared paper, 2019 · strength 0.08
- Paper Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. DOI 10.1002/smll.201900631 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.